The Part D Premium Protection Act of 2026 (H.R. 10185) is a bill introduced by Representative Gus M. Bilirakis on August 31, 2026. It aims to provide a one-year premium credit in 2027 for individuals enrolled in Medicare Part D prescription drug plans. This credit is designed to reduce the amount beneficiaries pay for their premiums, using the average premium reduction observed in a prior stabilization demonstration. The credit applies to all Medicare Part D enrollees and is funded by the federal government.
Supporters of the bill, including Representative Bilirakis, argue that it will extend premium relief for seniors without reinstating additional federal protections for insurers. They highlight that the bill directs a uniform premium credit to beneficiaries, aiming to preserve the benefits achieved through previous demonstrations without additional taxpayer-backed protections for insurance companies.
Critics express concern that the bill may not adequately address the underlying issues affecting Medicare Part D premiums. They point out that while the premium credit offers temporary relief, it does not tackle the structural factors contributing to rising drug costs. Additionally, some worry that without restoring certain federal protections for insurers, there could be unintended consequences affecting the stability of the Medicare Part D program.
The Part D Premium Protection Act of 2026, sponsored by Gus Bilirakis, presents a significant potential conflict of interest due to the substantial financial contributions from the health professionals sector. With $360 million in donations from health professionals, which directly overlaps with the bill's subject matter concerning health care premiums, there is a clear financial incentive for the sponsor to advocate for policies that may benefit these donors. The absence of PAC contributions suggests that the influence is primarily from individual donors, which can often indicate a more direct relationship between the sponsor and the contributors. Voters should be aware that this financial connection raises questions about whether the interests of health professionals are being prioritized over the public interest in health care affordability and accessibility.
These industries are both affected by this bill and among the sponsor's top donors.
| Industry | Match Type | Related Subject | Donations |
|---|---|---|---|
| Health Professionals (H01) | Sector | Health | $360,000,000 |
| Total from overlapping industries | $360,000,000 | ||
Top industries funding Gus Bilirakis, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
